title: A case of relapsed tardive dyskinesia due to clozapine dose reduction.
abstract: There is no proven effective treatment for tardive dyskinesia (TD). However, clozapine has been reported to be effective in suppressing TD symptoms. In this article, we report a TD case who received clozapine. The patient recovered from TD symptoms with a dose of 450 mg/day clozapine. At the end of the first year, clozapine was decreased to a dose of 250 mg/day and TD symptoms re-emerged.
authors.affiliation: Department of Psychiatry, Gulhane Military Medicine Faculty, Ankara, Turkey. ouzun@gata.edu.tr
authors.forename: O
authors.initials: O
authors.lastname: Uzun
authors.forename: A
authors.initials: A
authors.lastname: Cansever
authors.forename: A
authors.initials: A
authors.lastname: Ozsahin
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012008:Recurrence
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine